Finance

Beta
Lists
RAC:ASX
Racura Oncology Ltd
A$2.51
+1.21%
(+0.030) 1D
Jun 3, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RAC...
Open
A$2.60
High
A$2.60
Low
A$2.38
Mkt. cap
489.44M
Avg. vol.
166.21K
Volume
87.13K
52-wk high
A$4.90
52-wk low
A$1.12
EPS
-A$0.05
Shares outstanding
195.03M
Open
A$2.60
High
A$2.60
Low
A$2.38
Mkt. cap
489.44M
Avg. vol.
166.21K
Volume
87.13K
52-wk high
A$4.90
52-wk low
A$1.12
EPS
-A$0.05
Shares outstanding
195.03M
News stories
From sources across the web
About Racura Oncology Ltd
CEODaniel Tillett
Employees-
Founded2011
Headquarters-
SectorBiotechnology
Last report
Jan 28, 2026
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
1.53M / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
394.21K
394.21K
1.53M
1.53M
Cost of goods sold
127.77K
127.77K
127.77K
127.77K
Cost of revenue
127.77K
127.77K
127.77K
127.77K
Research and development expenses
1.73M
1.73M
1.72M
1.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.25M
1.25M
507.80K
507.80K
Operating expense
2.72M
2.72M
2.84M
2.84M
Total operating expenses
2.85M
2.85M
2.96M
2.96M
Operating income
-2.45M
-2.45M
-1.44M
-1.44M
Other non operating income
-11.59K
-11.59K
-42.62K
-42.62K
EBT including unusual items
-2.64M
-2.64M
-2.05M
-2.05M
EBT excluding unusual items
-2.64M
-2.64M
-1.48M
-1.48M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
106.10K
106.10K
175.95K
175.95K
Net income
-2.64M
-2.64M
-2.05M
-2.05M
Net profit margin
-670.89%
-670.89%
-134.33%
-134.33%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-181.50K
-181.50K
-
-
Net interest expenses
-181.50K
-181.50K
-
-
Depreciation and amortization charges
70.30K
70.30K
70.30K
70.30K
EBITDA
-2.38M
-2.38M
-1.37M
-1.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more